Cargando…
Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
PURPOSE: Interleukin-6 (IL-6) levels discriminate between patients with mild and severe COVID-19, making IL-6 inhibition an attractive therapeutic strategy. We conducted a systematic review, meta-analysis, trial sequential analysis (TSA), and meta-regression of randomized-controlled trials to ascert...
Autores principales: | Snow, Timothy Arthur Chandos, Saleem, Naveed, Ambler, Gareth, Nastouli, Eleni, Singer, Mervyn, Arulkumaran, Nishkantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139226/ https://www.ncbi.nlm.nih.gov/pubmed/34019122 http://dx.doi.org/10.1007/s00134-021-06416-z |
Ejemplares similares
-
Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
por: Snow, Timothy A.C., et al.
Publicado: (2021) -
“L'histoire se répète”, one size does not fit all. Author’s reply
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021) -
Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022) -
Steroids in ARDS: more light is being shed
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study
por: Longobardo, Alessia, et al.
Publicado: (2021)